Journal
/
/
Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
JoVE Journal
Medicine
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Medicine
Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
DOI:

06:29 min

May 25, 2022

Chapters

  • 00:04Introduction
  • 00:40Ocular Surface Disease Index Survey for Dry Eye Syndrome
  • 01:11Determination of Limbal Redness via AOS Software
  • 03:35Statistical Analysis
  • 04:40Results: Evaluation of Dry Eye Syndrome by OSDI and AOS
  • 05:43Conclusion

Summary

Automatic Translation

The present protocol describes the cross-sectional research performed on 40 healthy subjects between the ages of 20 and 45 to assess the prevalence of dry eye syndrome (DES) during COVID-19. The OSDI survey evaluated DES, and the advanced ophthalmic systems (AOS) software was used to assess limbal redness.

Related Videos

Read Article